34th Pharmacovigilance UK & EU 2024
This event has expired
Share
Now
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Speakers
KHAUDEJA B
Amgen
KHAUDEJA B
Amgen
KHAUDEJA BANO, Vice President, Combination Product Quality, Amgen (USA)
Khaudeja is a Physician with a Masters in Clinical Research, Pharmaceutical engineering Certification, a Database Administrator and a certified Project Management Professional.
Khaudeja has more than 25 years’ professional experience, including clinical practice. She has held several global medical positions at Guidant, Abbott, and AbbVie Inc. Her career includes global medical / clinical and safety leadership roles in devices, diagnostics, pharmaceuticals and combination products.
She currently serves as the chair for the Post Marketing Safety working group for the Combination Product Coalition (CPC).
FABIO D G
Shionogi Europe
FABIO D G
Shionogi Europe
FABIO DE GREGORIO, Vice President, Head of Drug Safety Europe, Shionogi Europe
• Dr De Gregorio serves as Vice President and Head of Drug Safety at Shionogi Europe, where he leads the European Pharmacovigilance Team.
• He has 25-year experience in the pharma industry in various roles, functions, and therapeutic areas.
• He has worked in pharmacovigilance since 2004 and spent more than 12 years as a QPPV.
• Among his achievements, he successfully set up the pharmacovigilance system of several small medium enterprises, and from the clinical development perspective, he received international awards for his researches on an innovative treatment for ocular hypotony.
• Dr De Gregorio graduated in Medicine from “La Sapienza” University of Rome, Italy, specialised in ophthalmology, which practised for over 20 years and has also a PhD in pathophysiology of ocular circulation.
SUMIT MUNJAL
Otsuka Pharmaceuticals
SUMIT MUNJAL
Otsuka Pharmaceuticals
SUMIT MUNJAL, Global Head of Medical Safety, Otsuka Pharmaceuticals
TANUJA HALADY
Merck KGaA
TANUJA HALADY
Merck KGaA
TANUJA HALADY, Senior Medical Director, Head of GPS Oncology Group III, Merck KGaA
JOHN SOLOMON
Sanofi
YVONNE N
Bayer
YVONNE N
Bayer
YVONNE NANCIU, Country Head Pharmacovigilance Deputy EU QPPV, Bayer
Medical doctor (Specialty: Clinical Genetics) with a wide clinical and laboratory expertise, holding a Masters´ degree in Pharmaceutical Medicine, and being passionate about Pharmacovigilance, Patient Safety and Engagement.
I have over 15 years of PV experience (global and local positions, clinical studies and post-marketing). Since February 2021, I am holding the position of Pharmacovigilance Country Head and German QPPV (Stufenplanbeauftragte) at Bayer in Germany. Additionally, I am a lecturer for Pharmacovigilance at various German Universities (under-and post-graduate studies).
PAV RISHIRAJ
Ipsen
PAV RISHIRAJ
Ipsen
PAV RISHIRAJ, Director, Head of Pharmacovigilance & ABPI PV Expert Chair, Ipsen
• A senior Pharmacovigilance (PV)/ Patient Safety leader and expert with extensive detailed experience spanning 21 years across multiple functions including global/local positions, Pav Rishiraj has held previous senior management/leadership positions, primarily alongside QPPVs/VP of PV to ensure strict compliance to UK, European and global regulatory obligations through robust implementation and oversights of the regional/local PV system. His experience locally and regionally has enabled facilitation of strong cross-functional collaboration and transformational change across all the organisations he has served. A proactive leader and energizer, through inclusive, empowering leadership, Pav Rishiraj ‘s passionate advocacy and empowering approach to patient safety is apparent in full abundance when he was recognised and installed as the UK Chair of the ABPI Pharmacovigilance Expert Network (PEN). He remains ever committed to ensuring and propelling forward innovative approaches to patient safety and is currently a member of the International Society of Pharmacovigilance (ISoP).
• Pav has both strategic and working experience of influencing, shaping, and advocating the PV landscape from an industry perspective- recent highlights include pre/post BREXIT discussions with the MHRA, ABPI PV expert guidance’s in addition to industry lead wider impact groups. Internally, he has led many teams to audit and inspection successes. Notably, one of his career highlights was his strategic contribution to an overall company-wide R&D strategy.
• Pav was recently appointed (May 2022) as a member of the Board Steering Group (BSG) at the ABPI by his peers and colleagues to represent UK PV and drive forward Regulatory Science objectives largely to evolve a robust and respected regulatory framework with clear strategy for collaboration within the UK and internationally.
MIJAL CHAVDA
Kyowa Kirin
MIJAL CHAVDA
Kyowa Kirin
MIJAL CHAVDA, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin
RAJ BHOGAL
Jazz Pharmaceuticals
RAJ BHOGAL
Jazz Pharmaceuticals
RAJ BHOGAL, Sr. Director, R&D Business Strategy & Operations, Jazz Pharmaceuticals
• Raj Kaur Bhogal, Sr. Director in Business Strategy & Operations.
• Raj previously headed up the R&D Audits & Inspections Team within Global Quality at Jazz Pharmaceuticals.
• Raj is a Quality Assurance Professional with 23 years of diverse Pharmaceutical Industry experience based in the UK. With a broad expertise in different GxPs e.g., GVP, GCP and GMP. Her areas of subject matter expertise include Quality Management System & Pharmacovigilance System.
• Raj spent 8 years in various Manufacturing roles at Eli Lilly & Company where she started as a placement student as part of her degree.
• In Raj’s 12 years at Shire/Takeda in the R&D Quality team she had the opportunity to lead the inspection readiness program, she also managed and hosted MAH, Supervisory Authority & many local PV system inspections (e.g., UK, EU, China, Saudi Arabia, South Africa, Australia) and also MHRA GCP Inspection. Raj participated in various due diligence activities, mergers, acquisitions and integration activities with various companies.
VALENTINA M
Shionogi Europe
VALENTINA M
Shionogi Europe
VALENTINA MANCINI, Senior Director Pharmacovigilance, QPPV, Shionogi Europe
MICHAEL BEAN
Johnson & Johnson
MICHAEL BEAN
Johnson & Johnson
MICHAEL BEAN, Senior Director, BioResearch Regulatory Compliance, Johnson & Johnson
ALINA TUDOR
Kyowa Kirin International
ALINA TUDOR
Kyowa Kirin International
ALINA TUDOR, Senior Director, Pharmacovigilance, Kyowa Kirin International
• Alina Tudor is a medical doctor with over 16 years of experience as drug safety physician.
• She has worked for both speciality pharma and generic companies, in clinical development and post marketing risk management.
• She currently is a Senior Director Pharmacovigilance, leading global safety teams for Kyowa Kirin, working with drugs and biologics in the rare disease area.
HUMAIRA Q
Qinecsa Solutions
HUMAIRA Q
Qinecsa Solutions
HUMAIRA QURESHI, President, Qinecsa Solutions
Senior Executive Leader with experience in leading successful Pharmacovigilance businesses in Health and Life Sciences Sector. A leader with strong management, strategic development and business development experience underpinned by extensive domain expertise over a 20+ year period.
JUDY BARRETTO
Roche
JUDY BARRETTO
Roche
JUDY BARRETTO, Global Process Owner, Signal Management Director, Roche
• Judy Barretto is the Signal Management Process owner with 19 years of pharmacovigilance experience.
• She has worked within clinical and affiliate functions with the majority of experience at the global level in signal and risk management as a safety scientist and process owner.
EVI MATHIOU
Novo Nordisk
EVI MATHIOU
Novo Nordisk
EVI MATHIOU, Legal, Compliance & Quality Director, Novo Nordisk
Evi Mathiou is Legal, Compliance and Quality Director in Novo Nordisk, with areas of responsibility the legal, compliance and quality support of the countries of Greece and Cyprus.
Evi is an Attorney-At-Law registered in the Athens Bar Association, licensed to litigate before the Supreme Court.
She is a member of the Legal and Compliance working groups of the Hellenic Association of Pharmaceutical Companies and of the Compliance working group of the Cypriot Association of Pharmaceutical Companiesas Novo Nordisk representative.
Evi has expertise in private, corporate and pharmaceutical law, in data protection law, in pharmaceutical compliance and quality assurance.
Prior to joining Novo Nordisk, Evi worked as Legal Manager in GSK Greece and as associate lawyer in Greek Law Firms with extended experience in commercial and corporate matters and in corporate litigation.
Evi graduated from the Law School of the National and Kapodistrian University of Athens and also completed Master’s degrees in Private Law (LLM) at the Law School of the National and Kapodistrian University of Athens and in International and European Studies (MA) at the Panteion University of Greece.
TEA BABIC
Teva
TEA BABIC
Teva
TEA BABIC, Director, PV Audits & Inspections, Teva
• I am a pharmacist with MSc in Clinical Pharmacology, and 18 years in pharmaceutical industry, in QA, PV and PV Compliance roles.
• After 3 years of working in QA in the beginning of career, I moved to PV where I gained experience with ICSR processing and reporting, periodic reports and RMP preparation before moving to PV compliance.
• I am conducting PV audits for 11 years and leading the PV audit and inspection group in Teva for the last 6 years.
ZINA SADEQ
Amicus Therapeutics
ZINA SADEQ
Amicus Therapeutics
ZINA SADEQ, Director, Regional PV & Alliance Management, Amicus Therapeutics
MARIANA C M
Sanofi
MARIANA C M
Sanofi
MARIANA CALZADA MIJANGOS, CHC Country Safety Head, Sanofi
"Mariana Calzada has a degree in Biological Pharmaceutical Chemistry from the National Autonomous University of Mexico, a diploma in Clinical Research and an expert course in Pharmacovigilance from the University of Alcala in Spain. She is currently a student of the Master in Medical Sciences.
She has 8 years of experience in Pharmacovigilance in the pharmaceutical industry. Currently works as CHC Country Safety Head for Sanofi in Mexico".
TERESA S
ITALFARMACO
TERESA S
ITALFARMACO
TERESA SARAGOCA, Director, Regulatory Affairs & Technical Manager, ITALFARMACO
“Specialist in Regulatory Affairs issued by the Specialty College of Portuguese Pharmaceutical Society, with a Master's degree in Regulation and Evaluation of Medicines and Health Products at University of Lisbon, and degree in Law at University of Lisbon ongoing. With 20 years’ experience in the pharmaceuticals industry, she developed skills in Negotiation, Budgeting, Business Planning, Management, and Teamwork.”
DNYANESHWAR S
Glenmark
DNYANESHWAR S
Glenmark
DNYANESHWAR SANAP, EU/UK QPPV, Head Regional Pharmacovigilance, Glenmark
• Dnyaneshwar or Dnyan (better known as Dan in indistry circle) is a qualified physician of Indian origin, with total experience of more than 17 years.
• Initiated career as a medical practitioner. After > 4 years of clinical practice experience and masters in pharmaceutical medicine (moreover upon developing interest into drug safety and clinical development field), joined pharma industry in 2009.
• His first encounter with PhV occured during pursuing masters training at a WHO zonal center for Indian National Pharmacovigilance program (KEM hospital, Mumbai; 2007-08)
• He has worked across PhV business models [academia (KEM Mumbai), vendor (TCS, Accenture), and sponsor-both developmental (AZ, UCB and BI) and post marketing (Sun /Taro and Glenmark)] since then.
• During his previous association with Boehringer Ingelheim, he was responsible for safety survillence of one of it’s blockbuster medicinal product and was involved in measuring effectiveness of additional risk minimisation measure and development of AI based tool for assessment of safety data.
• He is a qualified PV-QA auditor and a clinical trial medical monitor, has worked (as well as working) as EU-QPPV.
SIMON A
ONO PHARMACEUTICAL
SIMON A
ONO PHARMACEUTICAL
SIMON ASHWORTH, Head of Pharmacovigilance and Medical Safety, ONO PHARMACEUTICAL
He undertook his medical training in a number of London teaching hospitals, and received his medical degree from the University of London. He clinically specialised in Haematology and Oncology. After 9 years of clinical practice, he moved into the pharmaceutical industry, where he has worked for a number of companies including Eisai, Roche/Genentech/Chugai and GSK prior to joining Takeda in 2013.In 2019 he joined Autolus, a CAR-T therapy company, as the Head of Pharmacovigilance, prior to joining ONO in 2021.
He has 20 years experience in clinical safety and pharmacovigilance, including experience in early development, product registrations and both early and late post marketing safety surveillance.
GURPREET SINGH
IQVIA
GURPREET SINGH
IQVIAGURPREET SINGH, VP, Managing Director Integrated Safety, IQVIA • Gurpreet Singh is currently the Vice President, Managing Director Integrated Safety at IQVIA. He has a total of 18 years' experience in Pharma Industry of which 17 years have been in Global Drug Development. • During these years he has had the opportunity to work with some top Global companies like Cognizant, Tata Consultancy, Novartis and Parexel. • At Novartis he was the Global Head of PV Operations managing all Global PV activities. At Parexel he was the Senior Director PV Operations responsible for managing PV projects of top Global Pharma and Biotech companies. • Gurpreet is a certified Six Sigma and Project Management Professional. He has keen interest in Digital Transformation and Organization Culture and has successfully led various projects during his tenure in the Pharma Industry. He is an avid runner and a speaker at various Pharma conferences.
CINTHYA G Q
Pfizer
CINTHYA G Q
Pfizer
CINTHYA GALICIA QUINTANAR, Senior Manager, Country Safety Lead, Pfizer
• Cinthya has a Bachelor of Science (BS) degree in Chemical Pharmaceutical Biology graduated from National Autonomous University of Mexico (UNAM), Cinthya has a Master's Degree in Health Sciences- with specialization in Clinical Research from the Higher School of Medicine of the National Polytechnic Institute (ESM-IPN) and she is studying a PhD in Medical Research at the same institution.
• Cinthya has 14 years of experience in Pharmacovigilance and 10 years of experience as head of the Pharmacovigilance Unit in National and Regional Industry for LATAM countries.
• She is currently working for Pfizer México as Sr. Manager Country Safety Lead.
• She has several diplomas such as Signal Detection, Pharmacovigilance, Clinical Pharmacology, Clinical Pharmacy, Monitoring of Clinical Studies, Biostatistics applied to research among others.
• She has a diploma in Management Development from ICAMI and a diploma in Transformational Leadership from Tecnológico de Monterrey.
• President for Mexican Pharmacovigilance Association for the period 2021-2023.
MARIANNE M
Bayer
MARIANNE M
Bayer
MARIANNE MOUNIR, Senior Global System Auditor, Bayer
• Marianne Mounir is a professional in the pharmaceutical industry, witha career spanning over 20 years.
• Her journey began in the regulatory body of the Egyptian Ministry of Health, where she spent 12 years gaining invaluable exposure to all front lines of the pharmaceutical industry.
• Marianne's career took a significant turn when she delved into the field of Pharmacovigilance. Over the course of a decade, she has worn many hats –Regional PVHead, trainer, founder, and member of renowned industry groups.
• Her curiosity to learnand high enthusiasm for finding efficient ways to work led her to her current role as a Senior Global Auditor in Quality Assurance.
• In addition to her pharmacy degree, Marianne holds an MBA, which has enriched her understanding of the complexities of the pharmaceutical business.
JOHN POUSTIE
Haleon
JOHN POUSTIE
Haleon
JOHN POUSTIE, EMEA Director Pharmacovigilance and UK QPPV, Haleon
• John Poustie has over 20 years’ experience within Pharmacovigilance.
• He has led Pharmacovigilance functions within Large Pharma, Speciality Pharma and Consumer Health Organisations.
• He currently is the EMEA Pharmacovigilance Director and UK QPPV for Haleon working within consumer Health products.
RASHID AHMED
Worldwide Clinical Trials
RASHID AHMED
Worldwide Clinical Trials
RASHID AHMED, Director Pharmacovigilance, Worldwide Clinical Trials
Over 17 years experience in Pharmacovigilance with both pharmaceutical companies and CROs in numerous indications, through phases I-IV and post-marketing. I oversee the PV operations in Europe and Asia Pacific and the setup and maintenance of the safety database. I lead the integration of new PV regulations into PV process documents at Worldwide Clinical Trials.
FATIMA Y G
Makkah Healthcare Cluster
FATIMA Y G
Makkah Healthcare Cluster
FATIMA YOUSEF GHETHAN, Executive Administration of Institutional Excellence and Quality, Makkah Healthcare Cluster (Saudi Arabia)
DANIELA D C
Ferring Pharmaceuticals
DANIELA D C
Ferring Pharmaceuticals
DANIELA DI COSMO, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals
Daniela has worked in the PV field with different roles for over 10 years in multiple companies all around Europe. Currently she covers the Senior Safety Advisor role in the Global Safety department in Ferring Pharmaceuticals and she is based in Copenhagen.
DIMITRIS Z
Sandoz
DIMITRIS Z
Sandoz
DIMITRIS ZAMPATIS, Global Program Safety Lead, Sandoz
• He holds a BSc in Biology, a MSc in Medicinal Chemistry: Drug Design and Development, a MSc in Health Policy and Planning and a PhD in Cell and Molecular Biology.
• In his current role he is responsible to provide strategic input into safety aspects of assigned product(s), lead the pharmacovigilance processes and product safety reviews, review SOPs and guidelines, provide scientific input in signal, risk management and benefit risk assessment Outputs and reviews and act as key person for regulatory or internal audits and inspections.
• In his previous role as QPPV, he was overall responsible for all pharmacovigilance of all medicinal products for which the company holds marketing authorizations within the EU as also was heading the PV department for the EMEA region. In his previous roles as safety expert, he was responsible for the development of the company’s benefit-risk assessment framework, the signal detection strategy e.g.,quantitative, and qualitative signal detection methods using internal and external databases (EVDAS, VigiBase, FAERS, VAERS, JADER) as also the Risk Management and risk minimization measures processes and implementation.
• Through his career Dimitris gained substantial and solid knowledge and experience in different aspects of Drug Safety and Pharmacovigilance such as Signal Detection, RMPs, PBRERs/ PSURs, DSURs, safety communications (e.g., Direct Healthcare Professional Communication / Dear Investigator Letter). He participated in various successful FDA and EMA submission applications either as a team member or as team leader.
• Dimitris is a Pharmacovigilance tutor and trainer and participates in various conferences as a speaker. Also, Dimitris is a guest lecturer at the Master of Science (MSc) program Drug and Regulatory Affairs of the Pharmaceutical Department of the University of Nicosia (Cyprus).
GAURI UTTURKAR
UCB
GAURI UTTURKAR
UCB
GAURI UTTURKAR, Patient Safety Physician, UCB
• Gauri Utturkar has more than 13 years of pharma industry experience, starting her career with a CRO and now having an extensive patient safety experience within innovator and generic pharma.
• A medical graduate by education, she started her work in early patient safety activities in clinical trials and gradually moved on to pharmacovigilance in one of leading generic pharma companies where in she worked on early and late patient safety activities.
• She also worked as deputy EU QPPV and UK QPPV in this company before moving on to innovator pharma space.
• She is currently working as Associate director, Patient Safety in the role of safety physician for one of the leading products at UCB Pharmaceuticals.
ENIKO B K
Gedeon Richter
ENIKO B K
Gedeon Richter
ENIKO BARTA-KONDAS, Head Global PV Operations, Gedeon Richter
• Head of Global Pharmacovigilance Operation, Richter Gedeon Nyrt. in Budapest. A graduate of Bioengineering at Corvinus University of Budapest in 2015. Joined Richter Gedeon Nyrt. in 2016. Accumulated more than 6 years of experience in the pharmacovigilance area, managing worldwide operational activities.
• Responsible for leading and managing of outsourced activities for worldwide and local scientific literature screening, end-to-end case management, reconciliation. Overseeing the global system for the collection, processing and regulatory reporting of individual drug safety reports. Providing assistance and support for the work of the local pharmacovigilance officers of the subsidiaries. In charge of managing PV agreements with licence partners.
• Furthermore, ensuring cost-efficiency and daily compliance of pharmacovigilance systems especially of LifeSphere Safety MultiVigilance, LifeSphere EV Triage, Drug Safety Triager. Supervising a PV technology function and looking after system maintenance, change management, developing query strategy, enabling technology functions for business needs.
ALEXANDER R
Arnold & Porter
ALEXANDER R
Arnold & Porter
ALEXANDER ROUSSANOV, International Partner, Life Sciences and Privacy, Arnold & Porter
• Alexander Roussanov, a former senior legal adviser in the Legal Department of the European Medicines Agency (EMA), focuses his practice on a broad range of issues related to the life-cycle of medicinal products and medical devices. His experience includes product classification, authorization and conduct of clinical trials for medicinal products and clinical investigations for medical devices, marketing authorization for medicinal products and CE marking of medical devices, pharmacovigilance and device vigilance, marketing and promotion activities, privacy and data protection counseling, and interactions with health care professionals.
• He is well-versed in certain EMA-specific regulations, including those surrounding advanced therapy medicinal products, marketing authorization procedures, referral procedures, GxP inspections, the Agency's freedom of information policy and clinical data transparency. In addition, he has represented the EMA in litigation in the Court of Justice of the European Union.
• Mr. Roussanov advises clients on the form and terms of various types of agreements important for the efficient conduct of research activities including clinical study agreements, sponsor's representative agreements, registry agreements and CRO agreements. He also has experience in internal investigations, audits and regulatory due-diligence projects.
• He has extensive practical experience counseling organizations on data security and privacy matters. Mr. Roussanov has assisted clients with compliance requirements of Regulation (EU) 2016/679 (GDPR). He advises on many aspects of the GDPR that are of particular importance in the Life Sciences sector. These include the collection and processing of patients' personal health data and genetic data, transfer of personal health data outside the EU a nd the territorial scope of the GDPR.
Sample Attendees
Schedule
To learn more about Schedule of conference please download brochure.
Sponsors & Partners
Qinecsa Solutions
• Qinecsa is a trusted partner to global life science companies. We bring together best-in-class technology and scientific expertise to connect life science companies to the right safety solutions.
• Patient safety is at the forefront of pharmacovigilance. In a demanding and constantly evolving field, life science companies need expert partners with the right people, processes, and technologies, to generate vital safety insights, rapidly.
• Through our unique insight into the challenges of pharmacovigilance, we have created industry-leading, end-to-end solutions for capturing, managing, and evaluating drug safety data, more efficiently and accurately. Working with life science companies we drive progress to continue protecting lives.
• We are Qinecsa. Advancing drug safety solutions to the next level.
Visit our website: www.qinecsa.com
IQVIA Technologies
As one of the world's leading pharmacovigilance (PV) organizations, IQVIA brings extensive domain expertise and deep regulatory knowledge to every program. Our safety teams leverage automation, artificial intelligence (AI) and machine learning to design, build and execute end-to-end safety solutions. Powered by IQVIA Connected Intelligence – integrated, scalable technologies combined with global data, advanced analytics, and deep domain expertise – our innovative Safety solutions help PV organizations do more with less.
Visit Our Website: www.iqvia.com
Brookwood Global
Brookwood has been providing training since 1985. As well as numerous courses in GCP, risk management, GDPR and other related areas, Brookwood has developed six online, on-demand pharmacovigilance courses. These have been developed by Prof Dr David Hutchinson with PV and CQA specialist Lisbeth Tofte Hemmingsen. If you wish, all courses can be fully customized to meet client’s needs as well as branded with logo and corporate colours. They can be provided as managed training (registration, tracking, reporting, certification) or as Scorm files to run on a client’s own learning management system.
Summaries of all of Brookwood courses can be seen in the online brochure and in a paper copy to be provided at the 31st Pharmacovigilance 2023 conference in London.
https://brookwood-global.com/Brochures/Online-Training/
Brookwood’s PV course titles include …
- PV for ALL – a short 15 min module for anyone in an organisation, from receptionist to general manager, who is likely to encounter product safety information.
- Essential PV – a 60-min course for those needing more in-depth knowledge of generic PV requirements.
- PV for the Local Safety Contact and L-QPPV – for those in affiliates with a PV role and for those working with local Safety Contacts.
- PV Refresher – an interactive Q&A style course to refresh PV knowledge.
- Essential Safety Reporting for the Study Site – a short course to remind investigators of their safety reporting responsibilities.
- Are you ready for a PV inspection? – a guide for anyone needing to be ready for a PV inspection.
All modules are in English, but can be translated into any language at client request. Plenty of interaction, personalization, narrated or read-only options and integral quizzes to test knowledge are features of Brookwood courses.
Brookwood is also able to develop bespoke online training using your own content.
Feel free to contact us if you would like to evaluate any of the courses in our brochure.
Visit our website: www.brookwood-global.com
PharmaLex
PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. Together, PharmaLex and Cencora offer end-to-end product commercialization, including global market access strategy and execution, to drive patients’ healthier futures wherever they are in the world.
PharmaLex complements Cencora’s existing suite of services by continuing to service the pharma, biotech and medtech industries, guiding clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
Visit our website: www.pharmalex.com
DrugCards
DrugCard is the vanguard in AI-enabled pharmacovigilance solutions, modernizing drug safety practices across the globe. Our platform is designed to automate local literature screening, making it continuous, regular, transparent, multi-language, and cost-effective. And Why Choose DrugCard?
– AI-Enabled Efficiency: Leveraging advanced AI technology, DrugCard streamlines drug safety routines, reducing literature screening time by an impressive 70%.
– Global Reach with Local Expertise: DrugCard supports 100+ languages and covers medical journals in 47+ countries.
– Customizable Solutions: The only SaaS in the market that tailors its features to meet your specific needs. From automatic translation to user role management, we offer a suite of customizable features.
– Real-Time Analytics: platform provides real-time analysis, enabling pharmacovigilance teams to proactively identify new safety signals and evaluate risks, thereby enhancing patient safety.
Visit our website: https://drug-card.io/
Accuvigil
Accuvigil is a dynamic KPO in the world of pharmacovigilance, with its revolutionary approach and unparalleled commitment to drug safety and regulatory excellence. Our seasoned pharmacovigilance experts bring 30 years of combined experience to ensure the safety and efficacy of your products throughout their lifecycle. We offer comprehensive end-to-end pharmacovigilance solutions, making us the ideal partner for PV outsourcing for companies with or without established PV infrastructure. We provide top-notch services at competitive prices by harnessing the latest knowledge and state-of-the-art software from our strategic SAAS partnerships. Choose Accuvigil for proactive and dependable pharmacovigilance support, safeguarding both your brand and public health.
Visit Our Website: https://accuvigil.com
Freyr Solutions
Freyr Solutions is the largest, global, Regulatory solutions and services company that offers end-to-end Regulatory solutions to life sciences industries. The services include Regulatory affairs, pharmacovigilance, clinical research, quality management, and technology solutions such as Regulatory information management systems and Regulatory data integration. Freyr's expertise in Regulatory affairs makes it a trusted partner for life sciences companies seeking to navigate the complex Regulatory landscape.
Visit our website: www.freyrsolutions.com
Axian Consulting
Axian provide a comprehensive range of safety consulting and patient risk management services globally and across the product lifecycle for our pharma, biotech and medtech clients. We apply benefit-risk thinking along with structured design considerations to deliver risk management solutions that drive efficiency and compliance, allow providers to evaluate the effectiveness of their safety interventions, and optimise safety outcomes for patients.
Visit Our Website: www.axian.consulting.com
Virtue Insight
CONCEPTUALISED BY
Virtue Insight
CONCEPTUALISED BY
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
Testimonials
Bayer Country Head Pharmacovigilance Deputy EU QPPV
Amgen Senior Manager Global Patient Safety
Bayer Country Head Pharmacovigilance
Bausch Health PhV Manager
Pfizer Country Safety Lead UK & Ireland
Boehringer Ingelheim Emerging Markets
Takeda Regulatory Inspection Lead, Safety & International Global Quality
Teva Pharmaceutical PhV Manager
CSL Behring Director, Clinical Safety Physician
Vifor Pharma Global Head Medical & Clinical Drug Safety
Amgen Safety Executive Director
Shire Pharmaceuticals Safety Executive Director
Venue Details
Venue:
Sheraton Skyline, Heathrow, London
Address: Heathrow Airport, Bath Road, Hayes,
England, United Kingdom,
UB3 5BP
Phone : +44 20-87592535
Get Involved
Speaking Opportunities
Fen Castro
fen@virtueinsight.co.in
+91 44 42108101
Sponsor / Exhibit / Delegate Bookings
Piyush Patel
piyush@virtueinsightevents.com
+44 20 3509 3779
